Flynn James E 13D/13G Filings for Windtree Therapeutics, Inc. (WINT)

Flynn James E 13D and 13G filings for Windtree Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
08:53 am
Unchanged
2024-09-30 13G Windtree Therapeutics, Inc.
WINT
Flynn James E 0
0.000%
0
(Unchanged)
Filing